11,475 CVS Health Corporation $CVS Shares Sold by Jackson Square Capital LLC

Jackson Square Capital LLC cut its position in shares of CVS Health Corporation (NYSE:CVS) by 26.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 32,070 shares of the pharmacy operator’s stock after selling 11,475 shares during the quarter. Jackson Square Capital LLC’s holdings in CVS Health were worth $2,748,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of CVS. Grant Private Wealth Management Inc acquired a new position in shares of CVS Health during the 3rd quarter worth $678,000. SteelPeak Wealth LLC boosted its position in shares of CVS Health by 1,168.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 30,410 shares of the pharmacy operator’s stock worth $2,606,000 after buying an additional 28,013 shares in the last quarter. IFP Advisors Inc grew its stake in CVS Health by 44.8% in the 3rd quarter. IFP Advisors Inc now owns 13,957 shares of the pharmacy operator’s stock valued at $1,196,000 after acquiring an additional 4,319 shares during the last quarter. Delta Capital Management LLC grew its stake in CVS Health by 7.0% in the 3rd quarter. Delta Capital Management LLC now owns 17,900 shares of the pharmacy operator’s stock valued at $1,534,000 after acquiring an additional 1,170 shares during the last quarter. Finally, Center For Asset Management LLC grew its stake in CVS Health by 4.2% in the 3rd quarter. Center For Asset Management LLC now owns 3,438 shares of the pharmacy operator’s stock valued at $295,000 after acquiring an additional 139 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research reports. Truist Financial lifted their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Bank of America upped their price target on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Royal Bank Of Canada increased their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Weiss Ratings cut shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 9th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $107.80.

CVS Health Trading Down 1.3%

Shares of NYSE:CVS traded down $1.22 during trading on Monday, reaching $91.14. The stock had a trading volume of 1,875,086 shares, compared to its average volume of 8,343,972. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a market cap of $116.57 billion, a P/E ratio of 24.12, a PEG ratio of 0.86 and a beta of 0.60. The business has a fifty day moving average price of $91.74 and a 200-day moving average price of $93.19. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be paid a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Company Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.